Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Retension Pharmaceuticals, Inc.

NASDAQ: RTSN · Life Sciences · 3 alerts · CIK 2002988

Share price
$11.46Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Retension Pharmaceuticals, Inc. filings on SEC EDGAR ↗

6:12 PM ET Form 4
Insider Buying

Retension Pharmaceuticals CEO Eric L. Keller Buys $250K of Stock

Eric L. Keller, CEO, bought 20,800 shares of Retension Pharmaceuticals, Inc. at $12.00 a share, worth $250K in total on Oct 13, 2026. Shares held after the trade: 423,377 (+5.2%).

Value
$250K
Shares
20,800
Price
$12.00
Role
CEO
Holding change
+5.2%
Trade date
Oct 13, 2026
6:11 PM ET Form 4
Insider Buying

Retension Pharmaceuticals Insider Franklin M. Berger Buys $120K of Stock

Franklin M. Berger bought 10,000 shares of Retension Pharmaceuticals, Inc. at $12.00 a share, worth $120K in total on Oct 13, 2026. Shares held after the trade: 10,000.

Value
$120K
Shares
10,000
Price
$12.00
Trade date
Oct 13, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.